MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adlai Nortye Ltd. - American Depositary Shares (NQ:ANL)

7.860 -1.330 (-14.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 382,011
Open 9.200
Bid (Size) 7.400 (200)
Ask (Size) 7.980 (300)
Prev. Close 9.190
Today's Range 7.210 - 9.200
52wk Range 0.8786 - 12.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Adlai Nortye Announces First Patient Enrolled in Global Phase 1 Trial of Pan-RAS (ON) Inhibitor AN9025 for Solid Tumors Harboring RAS Mutations
From Adlai Nortye Ltd.
Via GlobeNewswire
What's going on in today's session ↗
Via Chartmill

Performance

YTD
+469.6%
+469.6%
1 Month
+20.4%
+20.4%
3 Month
+434.7%
+434.7%
6 Month
+341.6%
+341.6%
1 Year
+247.8%
+247.8%

More News

Read More
News headline image
Adlai Nortye Announces $140.0 Million Private Placement Equity Financing
From Adlai Nortye Ltd.
Via GlobeNewswire
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Top movers in Thursday's session ↗
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Adlai Nortye Enters Exclusive License Agreement with ASK Pharm for Pan-RAS (ON) Inhibitor AN9025 in Greater China
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye to Participate in Upcoming Investor Conferences
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye to Present Short Talk on AN4035 Preclinical Results at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
From Adlai Nortye Ltd.
Via GlobeNewswire
News headline image
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
From Adlai Nortye Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Adlai Nortye Ltd. - American Depositary Shares publicly traded?
Yes, Adlai Nortye Ltd. - American Depositary Shares is publicly traded.
What exchange does Adlai Nortye Ltd. - American Depositary Shares trade on?
Adlai Nortye Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Adlai Nortye Ltd. - American Depositary Shares?
The ticker symbol for Adlai Nortye Ltd. - American Depositary Shares is ANL on the Nasdaq Stock Market
What is the current price of Adlai Nortye Ltd. - American Depositary Shares?
The current price of Adlai Nortye Ltd. - American Depositary Shares is 7.860
When was Adlai Nortye Ltd. - American Depositary Shares last traded?
The last trade of Adlai Nortye Ltd. - American Depositary Shares was at 02/27/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story